Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Falklands Business Journal.
Press releases published on April 21, 2025

American Tungsten Corp. to Participate at Top Shelf Partners Commodities Global Expo 2025
Vancouver, BC, April 21, 2025 (GLOBE NEWSWIRE) -- American Tungsten Corp. (CSE:TUNG) (OTCQB:DEMRF) (FSE:RK9) (“American Tungsten” or the “Company”) is pleased to announce its attendance and participation at Top Shelf Partners Commodities Global Expo 2025. …

Zevra Files Definitive Proxy Statement and Mails Letter to Stockholders
Highlights 54.8% Total Stockholder Return Under Refreshed Board and Management Team Zevra Continues Growth Trajectory into a Global Commercial Rare Disease Company with Consistent Execution, New Product Launches, and Significant Financial Flexibility to …

BioStem Technologies to Present at the Centri Capital Conference
POMPANO BEACH, Fla., April 21, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, is pleased to …

Kraig Biocraft Laboratories Provides Production Update on Recombinant Spider Silk Operations
ANN ARBOR, Mich., April 21, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), a world leader in spider silk technology*, is pleased to provide an update on recombinant spider silk production. The …

HBT Financial, Inc. Announces First Quarter 2025 Financial Results
First Quarter Highlights Net income of $19.1 million, or $0.60 per diluted share; return on average assets (“ROAA”) of 1.54%; return on average stockholders' equity (“ROAE”) of 13.95%; and return on average tangible common equity (“ROATCE”)(1) of 16.20% …

Invivyd Announces $30M Non-dilutive Loan Facility with Silicon Valley Bank
WALTHAM, Mass., April 21, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that it has signed a $30 million term loan facility with …

Arvinas to Present Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at 2025 American Association for Cancer Research® (AACR) Annual Meeting
NEW HAVEN, Conn., April 21, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company working to develop a new class of drugs based on targeted protein degradation, today announced that new preclinical combination data …

Northland Power Appoints New Chief Financial Officer
TORONTO, April 21, 2025 (GLOBE NEWSWIRE) -- Northland Power Inc. (TSX: NPI) (“Northland” or the “Company”) announced today the appointment of Jeff Hart as the Company’s new Chief Financial Officer (CFO), effective May 1, 2025. Mr. Hart brings a wealth of …

BioCryst to Report First Quarter 2025 Financial Results on May 5
RESEARCH TRIANGLE PARK, N.C., April 21, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its first quarter 2025 financial results on Monday, May 5, 2025. BioCryst management will host a …

CECO Environmental to Release First Quarter Earnings and Host Conference Call on April 29
ADDISON, Texas, April 21, 2025 (GLOBE NEWSWIRE) -- CECO Environmental Corp. (Nasdaq: CECO), a leading environmentally focused, diversified industrial company whose solutions protect people, the environment and industrial equipment, today announced that it …

Amicus Therapeutics to Announce First Quarter 2025 Financial Results on May 1, 2025
PRINCETON, N.J., April 21, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Thursday, May 1, 2025, at 8:30 a.m. ET to discuss financial results for the first …

USA Rare Earth Announces Date for First Quarter 2025 Results and Conference Call
STILLWATER, Okla., April 21, 2025 (GLOBE NEWSWIRE) -- USA Rare Earth, Inc. (Nasdaq: USAR) (USAR or the Company), today announced that it will release financial results for the quarterly period ended March 31, 2025, after U.S. markets close on Wednesday, …

ROCKET LAB USA, INC. (NASDAQ: RKLB) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Rocket Lab USA, Inc. Investors of Upcoming Deadline
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of Rocket Lab USA, Inc. (NASDAQ: RKLB)? Did you purchase your shares between November 12, 2024 and February 25, 2025, inclusive? Did you lose money in your …

Immunovant Announces Next Phase of Growth with Roivant Including Changes to its Leadership Team and Additional Indications Sjögren’s Disease (SjD) and Cutaneous Lupus Erythematosus (CLE) for IMVT-1402
Eric Venker, M.D. (currently President and COO of Roivant) appointed as CEO of Immunovant and Tiago Girao appointed as CFO of Immunovant Pete Salzmann, M.D. retired from his role as Immunovant CEO and Director Leadership change is part of a broader …

Cryptocurrency has quietly become the preferred asset reserve for investment, and KSD Miner is very popular among users around the world.
London, UK, April 21, 2025 (GLOBE NEWSWIRE) -- From Change to Big Cash: How to Make $1 Million with $100 in 2025 As times have changed, Will the US tariffs lead to a depreciation of the US dollar? Cryptocurrency has quietly become the preferred asset …

Elixir AI Blazes into Web3 — Achieves 10x Growth on Launch Day
New York, NY, April 21, 2025 (GLOBE NEWSWIRE) -- In just 24 hours, Elixir AI made waves across the crypto world. Officially launched on April 19, the AI-powered 3D content generation platform saw its native token $ELXAI skyrocket by 10x, signaling early …

AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
LONDON and PHOENIX, Ariz., April 21, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced that its Chairman of the Board, Mr. Gabriele …

OTC Markets Group Announces Quarterly Index Performance and Rebalancing
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated financial markets for 12,000 U.S. and global securities, today announced the first quarter 2025 performance and quarterly rebalancing of the OTCQX® …

OTC Markets Group Welcomes Enzo Biochem, Inc. to OTCQX
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Enzo Biochem, Inc. (OTCQX: ENZB), life sciences company, has qualified to …

Apellis Announces Craig Wheeler to Join the Board of Directors
WALTHAM, Mass., April 21, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that Craig Wheeler, founder and chief executive officer of Headwaters Biotech Advisors, will join the Apellis Board of Directors, effective …